Date: Apr 27, 2022

5:30 pm (India) | 8 am EDT | 2 pm CEST

Read Additional Q&A from the Webinar

View Recorded Q&A

Join Dr. Deepak Gupta as he explores the role of Total Body Irradiation (TBI) in the treatment of hematologic malignancies. The objective of this webinar is to explain the background & rationale of treatment, clinical application, and clinical experiences utilizing TomoTherapy®/Radixact® Treatment Systems. Dr. Gupta will share the experience of the Medanta Cancer Institute, TBI TomoTherapy program.

Dr. gupta

Deepak Gupta M.D., Senior Consultant, Division of Radiation Oncology, Medanta Cancer Institute, Medanta - The Medicity, Gurgaon, Haryana
Dr. Deepak Gupta received his MBBS, MD (Radiotherapy) from CSSMU (Erstwhile KGMU), Lucknow. Dr. Gupta's Senior Residency was held at TMH Mumbai. Presently he is working as a Senior Consultant, Division of Radiation Oncology, Medanta Cancer Institute, Medanta, The Medicity, Gurgaon, Haryana. He has received numerous awards including the ESTRO Accuray award, ESTRO 33 conference in Vienna 2014.

Dr. Gupta has published 60 International/National publications and 4 chapter books.
 

Dr. Shueng

Moderated by: Pei-Wei Shueng, M.D., Department of Radiation Oncology, Far Eastern Memorial Hospital, Taiwan
Dr. Pei-Wei Shueng attended the School of Medicine, National Defense Medical Center, Taipei, Taiwan. He is the Chief Radiation Oncologist at the Division of Radiation Oncology, Department of Radiology, Far Eastern Memorial Hospital, New Taipei City, Taiwan, and Assistant Professor, National Yang-Ming University, Taipei, Taiwan.  He has received numerous awards including the First Global Experience of Helical Irradiation of Total Skin (HITS), Award for Symbol of National Quality (SNQ) of TomoTherapy® in Taiwan, and Award for Practical Application of shared decision making on Image-guided radiotherapy in Taiwan.

Dr. Pei-Wei Shueng's research interests include Intensity-modulated radiation therapy ( IMRT), Image-guided radiation therapy ( IGRT), Radiotherapy plus chemotherapy in Head and neck malignancy, breast, gynecological, and prostate cancer. Dr. Pei-Wei Shueng has published 120 peer-review articles from 1989-to 2022.